MentionFox
Home › funding signals › Panoptive
Accelerator · announced

Panoptive (YC S25) — The continuous oversight engine for clinical trials

We turn unstructured monitoring data - monitoring visit reports, EDC data - into structured deviation, safety, and quality findings for human review. Panoptive generates an audit-ready oversight trail as a natural byproduct.

Panoptive is a Y Combinator company in the Summer 2025 batch. Its directory entry describes it as: The continuous oversight engine for clinical trials. The founder listed is Youssef Kallel (Founder/CEO) (Y Combinator directory entry, July 24, 2025).

6 more companies from YC Summer 2025 ↓

Run the free check on Panoptive →

Sell to companies like Panoptive? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Panoptive

New accelerator entry · 2025-07-24 · the record

Summer 2025
batch
2
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchSummer 2025
Announced2025-07-24
StageEarly
StatusActive
Team size2
IndustryB2B
Sub-industryB2B
SectorsB2B, Biotech, Infrastructure, AI
RegionsUnited States of America, America / Canada
BasedSan Francisco, CA, USA
HiringNo
Sitehttps://www.panoptive.com
Previously known asAgentHub

Pitching, partnering or investing alongside them? See who really runs and owns Panoptive.

Free to see. No signup.

Keep reading

More on Panoptive and the records around it.

Also in YC Summer 2025

Same batch, B2B first.

What do you want to do with Panoptive?

Get the full cited report on Panoptive

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Panoptive: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

We turn unstructured monitoring data - monitoring visit reports, EDC data - into structured deviation, safety, and quality findings for human review. Panoptive generates an audit-ready oversight trail as a natural byproduct. The platform aggregates findings and identifies systemic patterns across sites and subjects before they compound, and tracks every finding through decision, follow-up, and resolution.

Want the whole picture on Panoptive?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Panoptive: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Panoptive covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Panoptive: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Panoptive. With no account yet, you sign up free and land on the result.

On these startup lists

Cloud infrastructure startups Healthcare and health tech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Panoptive: Accepted into Y Combinator Summer 2025
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-panoptive
Last updated 2026-10-20
Primary record: Y Combinator directory entry
Panoptive (YC S25) — The continuous oversight engine for clinical trials. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-panoptive